Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3670-1 (MIR3670-1) is a member of the microRNA (miRNA) family—short (20-24 nucleotide) non-coding RNAs that regulate gene expression post-transcriptionally by binding target messenger RNAs (mRNAs) and inhibiting their translation or promoting degradation. These miRNAs undergo a biogenesis pathway involving RNA polymerase II transcription, cleavage by Drosha and Dicer nucleases, and incorporation into the RNA-induced silencing complex (RISC), where they mediate gene silencing. MIR3670-1 is thus part of these general regulatory processes but has no uniquely well-defined role, molecular pathway, or disease association distinct from those generally attributed to human miRNAs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3670-1 (MIR3670-1).